Module 5: Clinical Outcomes by Disease Site - Tumor Control and Retreatment with Proton Therapy


Secure Content

If you would like to request to license this or any other OncoLink content for your corporate or educational purposes, please contact our Director of Strategic Partnerships for pricing

Maggie Hampshire RN, BSN, OCN
Director of Strategic Partnerships
OncoLink
3400 Civic Center Boulevard, Suite 2338
Philadelphia, PA 19104

215-349-5445 (fax)
hampshire@uphs.upenn.edu


News
ASTRO: Combination Therapy Beneficial in Prostate Cancer

Oct 2, 2014 - Long-term survival may be increased in medium-risk prostate cancer patients who receive short-term androgen deprivation therapy before and during radiation treatment compared with men who receive radiation alone. In addition, proton beam therapy may be associated with a decreased risk of disease recurrence after 10 years and has minimal side effects after one year, according to research presented at the 51st Annual Meeting of the American Society for Radiation Oncology, held from Nov. 1 to 5 in Chicago.



I Wish You Knew

What is Photodynamic Therapy and how is it used in cancer care?

View More







OncoLink OncoPilot

Facing a new cancer diagnosis or changing the course of your current treatment? Let our cancer nurses help you through!

Learn More